Monica Brady - May 23, 2022 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role
Chief Accounting Officer
Signature
/s/ Monica Brady
Stock symbol
PRPH
Transactions as of
May 23, 2022
Transactions value $
-$932
Form type
4
Date filed
5/25/2022, 05:18 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRPH Common Stock, par value $0.0005 Options Exercise $53.8K +25K +336.56% $2.15 32.4K May 23, 2022 Direct F1
transaction PRPH Common Stock, par value $0.0005 Options Exercise $45.3K +14.3K +43.94% $3.18 46.7K May 23, 2022 Direct F1
transaction PRPH Common Stock, par value $0.0005 Tax liability -$100K -11.8K -25.29% $8.47 34.9K May 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Options Exercise $0 -25K -100% $0.00* 0 May 23, 2022 Common Stock 25K $2.15 Direct F1, F2
transaction PRPH Option (right to buy) Options Exercise $0 -14.3K -28.5% $0.00 35.8K May 23, 2022 Common Stock 14.3K $3.18 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 23, 2022, the Reporting Person acquired net 27,444 shares of common stock upon the exercise of stock options to purchase 39,250 shares of common stock, less 11,806 shares of common stock withheld to cover the exercise price and applicable taxes.
F2 25% of the shares subject to this option were vested and exercisable as of September 26, 2017, the date of grant, and the remaining 75% of the shares vested in three annual installments beginning on September 26, 2018.
F3 These options vest in four equal annual installments beginning December 4, 2019, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of December 4, 2018.